MedX Health Corp (CVE:MDX – Get Free Report) shares reached a new 52-week low on Monday . The stock traded as low as C$0.05 and last traded at C$0.05, with a volume of 53300 shares traded. The stock had previously closed at C$0.06.
MedX Health Stock Performance
The stock has a market capitalization of C$16.40 million, a PE ratio of -5.00 and a beta of 0.63. The stock’s 50 day moving average is C$0.06 and its two-hundred day moving average is C$0.06.
MedX Health Company Profile
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market. It operates DermSecure telemedicine platform that enables the web-based operation of its SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients' mole and lesion images along with other relevant patient information can be connected to specialist physicians for remote assessment.
Featured Stories
- Five stocks we like better than MedX Health
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for MedX Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedX Health and related companies with MarketBeat.com's FREE daily email newsletter.
